These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35384044)

  • 21. Pleiotropic roles of melatonin in endometriosis, recurrent spontaneous abortion, and polycystic ovary syndrome.
    Yang HL; Zhou WJ; Gu CJ; Meng YH; Shao J; Li DJ; Li MQ
    Am J Reprod Immunol; 2018 Jul; 80(1):e12839. PubMed ID: 29493042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticancer properties of melatonin and its role as an adjuvant in cancer treatment.
    Nair A
    Indian J Cancer; 2022; 59(2):288-294. PubMed ID: 35946192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melatonin and pancreatic cancer: Current knowledge and future perspectives.
    Tamtaji OR; Mirhosseini N; Reiter RJ; Behnamfar M; Asemi Z
    J Cell Physiol; 2019 May; 234(5):5372-5378. PubMed ID: 30229898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting immune checkpoints in hematological malignancies.
    Salik B; Smyth MJ; Nakamura K
    J Hematol Oncol; 2020 Aug; 13(1):111. PubMed ID: 32787882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melatonin: new insights on its therapeutic properties in diabetic complications.
    Pourhanifeh MH; Hosseinzadeh A; Dehdashtian E; Hemati K; Mehrzadi S
    Diabetol Metab Syndr; 2020; 12():30. PubMed ID: 32280378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Melatonin and hypothalamic-pituitary-gonadal axis.
    Shi L; Li N; Bo L; Xu Z
    Curr Med Chem; 2013; 20(15):2017-31. PubMed ID: 23410151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment.
    Farhood B; Goradel NH; Mortezaee K; Khanlarkhani N; Najafi M; Sahebkar A
    J Cell Physiol; 2019 May; 234(5):5613-5627. PubMed ID: 30238978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the nexus of nuclear receptors in hematological malignancies.
    Manickasamy MK; Sajeev A; BharathwajChetty B; Alqahtani MS; Abbas M; Hegde M; Aswani BS; Shakibaei M; Sethi G; Kunnumakkara AB
    Cell Mol Life Sci; 2024 Feb; 81(1):78. PubMed ID: 38334807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melatonin as a potential inhibitor of kidney cancer: A survey of the molecular processes.
    Maleki Dana P; Reiter RJ; Hallajzadeh J; Asemi Z; Mansournia MA; Yousefi B
    IUBMB Life; 2020 Nov; 72(11):2355-2365. PubMed ID: 32918860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melatonin Attenuates Methamphetamine-Induced Neurotoxicity.
    Wongprayoon P; Govitrapong P
    Curr Pharm Des; 2016; 22(8):1022-32. PubMed ID: 25248807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological Effects of Melatonin as Neuroprotectant in Rodent Model: A Review on the Current Biological Evidence.
    Tan HY; Ng KY; Koh RY; Chye SM
    Cell Mol Neurobiol; 2020 Jan; 40(1):25-51. PubMed ID: 31435851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melatonin and its mechanism of action in the female reproductive system and related malignancies.
    Ezzati M; Velaei K; Kheirjou R
    Mol Cell Biochem; 2021 Aug; 476(8):3177-3190. PubMed ID: 33864572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melatonin.
    Piccirillo JF
    Prog Brain Res; 2007; 166():331-3. PubMed ID: 17956796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic role of controlling nutritional status score in hematological malignancies.
    Zhang Y; Chen Q; Lu C; Yu L
    Hematology; 2022 Dec; 27(1):653-658. PubMed ID: 35622088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melatonin in diseases of the oral cavity.
    Gómez-Moreno G; Guardia J; Ferrera MJ; Cutando A; Reiter RJ
    Oral Dis; 2010 Apr; 16(3):242-7. PubMed ID: 19682319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Potential Oncostatic Effects of Melatonin against Prostate Cancer.
    Samanta S
    Crit Rev Oncog; 2021; 26(3):53-67. PubMed ID: 35377986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melatonin Increases Bone Mass around the Prostheses of OVX Rats by Ameliorating Mitochondrial Oxidative Stress via the SIRT3/SOD2 Signaling Pathway.
    Zhou W; Liu Y; Shen J; Yu B; Bai J; Lin J; Guo X; Sun H; Chen Z; Yang H; Xu Y; Geng D
    Oxid Med Cell Longev; 2019; 2019():4019619. PubMed ID: 31110599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurobiological effects of melatonin as related to cancer.
    Hoang BX; Shaw DG; Pham PT; Levine SA
    Eur J Cancer Prev; 2007 Dec; 16(6):511-6. PubMed ID: 18090123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melatonin: A promising agent targeting leukemia.
    Shafabakhsh R; Mirzaei H; Asemi Z
    J Cell Biochem; 2020 Apr; 121(4):2730-2738. PubMed ID: 31713261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melatonin and the Brain-Heart Crosstalk in Neurocritically Ill Patients-From Molecular Action to Clinical Practice.
    Bekała A; Płotek W; Siwicka-Gieroba D; Sołek-Pastuszka J; Bohatyrewicz R; Biernawska J; Kotfis K; Bielacz M; Jaroszyński A; Dabrowski W
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.